Menu
/REGISTER
Montecito
Nixon Peabody
Chase
Bank of America
Loading...
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen wins new FDA approval for cancer drug Xgeva

By   /   Friday, January 5th, 2018  /   Comments Off on Amgen wins new FDA approval for cancer drug Xgeva

    Print       Email
The largest international study of multiple myeloma, in which more than 1,700 patients participated, netted Amgen a new approval from the U.S. Food and Drug Administration. The Thousand Oaks biotech company announced Jan. 5 that its treatment Xgeva had gotten approval from regulators to treat multiple myeloma patients after showing that it effectively blocks proteins…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Developer plans to add 1,270 homes to the Nipomo region

Read More →